Solar Pharma: Solar Pharma’s Q2 nos draw value upgrades, inventory hits 7-yr excessive
[ad_1] Mumbai: Higher-than-expected second-quarter earnings by , coupled with a powerful commentary, resulted in a pointy upward revision in earnings
Read More[ad_1] Mumbai: Higher-than-expected second-quarter earnings by , coupled with a powerful commentary, resulted in a pointy upward revision in earnings
Read More[ad_1] Home equities are more likely to lengthen good points as benchmark indices ending above psychologically essential ranges on Monday
Read More[ad_1] , a part of the pharma sector, which has rallied greater than 200% from COVID low of 2020 may
Read More